UnitedHealth Group (NYSE: UNH) has seen its stock price drop over 40% from its late 2024 high and is down nearly 30% this year, leading some to perceive the company as retreating. The firm is exiting more than 100 Medicare Advantage plans, affecting up to 180,000 beneficiaries across 16 states, raising concerns about its future stock trajectory.
